Skip to content
OpenCapital
Get started

Plus Therapeutics PSTV Q4 2024 Annual earnings

Reported March 27, 2025 · After market close

Revenue$1.4MMiss by $96.0K
EPS-$0.67Miss by $0.16
Revenue estimate$1.5M
EPS estimate-$0.51

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$1.1M
EPS estimate-$0.88

Versus estimates

Revenue

Q1 2026$1.0MBeat by $54.0KQ4 2025$1.4MBeat by $131.0KQ3 2025$1.4MMiss by $97.8KQ2 2025$1.4MMiss by $96.3KQ1 2025$1.1MMiss by $424.3K
Q4 2024$1.4MMiss by $96.0K

Diluted EPS

Q1 2026-$1.05Miss by $0.10Q4 2025-$0.83Miss by $0.03Q3 2025-$0.04Miss by $0.02Q2 2025-$0.01Beat by $0.08Q1 2025-$0.56Miss by $0.31
Q4 2024-$0.67Miss by $0.16

Ask the moment Plus Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Plus Therapeutics report Q4 2024 earnings?
Plus Therapeutics (PSTV) reported Q4 2024 earnings on March 27, 2025 after market close.
What were Plus Therapeutics's Q4 2024 revenue and EPS?
Plus Therapeutics reported revenue of $1.4M and eps of $-0.67 for Q4 2024.
Did Plus Therapeutics beat estimates in Q4 2024?
Revenue missed the consensus estimate of $1.5M by $96.0K. EPS missed the consensus estimate of $-0.51 by $0.16.
Where can I find Plus Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-047698) directly on SEC EDGAR. The filing index links above go to sec.gov.